Search Results - "Huber VC"

So You Want to be an Author: A Primer on Writing for Publication in the Medical Literature Part I: Manuscript Preparation.

Authors: Huber VC Vogt HB

Source: South Dakota medicine : the journal of the South Dakota State Medical Association [S D Med] 2016 Apr; Vol. 69 (4), pp. 172-5.

Publication Type: Journal Article

Journal Info: Publisher: South Dakota State Medical Association Country of Publication: United States NLM ID: 101265265 Publication Model: Print Cited Medium: Print ISSN: 0038-3317 (Print) Linking ISSN: 00383317 NLM ISO Abbreviation: S D Med Subsets: MEDLINE

So You Want To Be An Author: A Primer On Writing For Publication In The Medical Literature Part II: Manuscript Submission.

Authors: Huber VC Vogt HB

Source: South Dakota medicine : the journal of the South Dakota State Medical Association [S D Med] 2016 May; Vol. 69 (5), pp. 221-223.

Publication Type: Journal Article

Journal Info: Publisher: South Dakota State Medical Association Country of Publication: United States NLM ID: 101265265 Publication Model: Print Cited Medium: Print ISSN: 0038-3317 (Print) Linking ISSN: 00383317 NLM ISO Abbreviation: S D Med Subsets: MEDLINE

Immunogenicity of two representative American consensus scorpion neurotoxins from the genera Tityus and Centruroides.

Authors: Cardoso-Arenas, Samuel Mejia-Sanchez, Miguel Angel Miranda-Blancas, Ricardo et al.

Source: PLoS Neglected Tropical Diseases. 2/27/2026, Vol. 20 Issue 2, p1-22. 22p.

N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus.

Authors: Wang, Yang Gao, Yu Ma, Tianxin et al.

Source: PLoS Pathogens. 9/8/2025, Vol. 21 Issue 9, p1-22. 22p.

Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to mice.

Authors: Matthys, Arne Amelinck, Laura Smet, Anouk et al.

Source: PLoS ONE. 3/23/2026, Vol. 21 Issue 3, p1-10. 10p.

Multifocal native septic arthritis limited to peripheral small joints caused by Streptococcus pyogenes.

Authors: Ishiguro, K Suda, Y Kanaji, M et al.

Source: Scandinavian Journal of Rheumatology. Apr2026, p1-3. 3p. 1 Illustration.

A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions.

Authors: Khalid, Kanwal Ahmad, Fiaz Anwar, Ayaz et al.

Source: Molecular Biotechnology. Jan2026, Vol. 68 Issue 1, p1-22. 22p.

Conceptual Methodological Framework for Incorporating Antimicrobial Resistance Considerations in Economic Models for Pneumococcal Conjugate Vaccines.

Authors: Rozenbaum, Mark H. Tort, Maria J. Chapman, Ruth et al.

Source: Infectious Diseases & Therapy. Dec2025, Vol. 14 Issue 12, p2853-2868. 16p.

One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.

Authors: Šušol, Ondrej Šušolová, Barbora Klempíř, Ondřej et al.

Source: Cancer Medicine. Dec2024, Vol. 13 Issue 24, p1-10. 10p.

Group A Streptococcus Disease Outbreak Associated with Large Congregate Shelter, Chicago, Illinois, USA, October 2023–January 2024.

Authors: Toews, Karrie-Ann Tietje, Lauren Meyers, Anne et al.

Source: Emerging Infectious Diseases. Jun2026, Vol. 32 Issue 6, p858-864. 7p.

Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation.

Authors: Yan, Guiling Hu, Zhongwen Peng, Yuanyuan et al.

Source: Scientific Reports. 11/18/2025, Vol. 15 Issue 1, p1-14. 14p.

Epidemiological characteristics and spatio-temporal analysis of influenza in Sichuan Province from 2015 to 2024.

Authors: Li, Zhirui Zhou, Lijun Wang, Peihan et al.

Source: BMC Infectious Diseases. 9/26/2025, Vol. 25 Issue 1, p1-13. 13p.

Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

Authors: Zhu, Xinyu Luo, Zhaochen Leonard, Rebecca A. et al.

Source: PLoS Pathogens. 1/22/2025, Vol. 21 Issue 1, p1-20. 20p.

Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study.

Authors: Chorão, Pedro Avendaño, Alex Heras, Inmaculada et al.

Source: BMC Infectious Diseases. 7/25/2025, Vol. 25 Issue 1, p1-13. 13p.

The presence of yeasts and bacteria in free-living amoebae isolated from COVID-19 patients: concern for secondary infections.

Authors: Mirabedini, Zahra Niyyati, Maryam Mohammad Rahimi, Hanieh et al.

Source: International Journal of Environmental Health Research. Jul2025, Vol. 35 Issue 7, p1846-1859. 14p.

Computational identification of novel therapeutic candidates for Streptococcus pyogenes and influenza A coinfections through transcriptomic-based drug repositioning.

Authors: Strey K Sueto S Fuellen G et al.

Source: BMC microbiology [BMC Microbiol] 2026 Apr 23; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 23.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180 (Electronic) Linking ISSN: 14712180 NLM ISO Abbreviation: BMC Microbiol Subsets: MEDLINE

Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study.

Authors: Oliver, Jane Thielemans, Elise McMinn, Alissa et al.

Source: BMC Public Health. 12/30/2019, Vol. 19 Issue 1, p1-10. 10p. 2 Charts, 3 Graphs.

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.

Authors: Chua, Brendon Y. Sekiya, Toshiki Koutsakos, Marios et al.

Source: PLoS Pathogens. 10/7/2022, Vol. 18 Issue 10, p1-23. 23p.

Changing trends in Streptococcus pyogenes bacteraemia in adults in the post-COVID era.

Authors: Džupová, Olga Bartoš, Hynek Sýkorová, Blanka et al.

Source: BMC Infectious Diseases. 5/27/2025, Vol. 25 Issue 1, p1-6. 6p.

Editorial: Host Innate Immune Response and Its Impact on Pulmonary Pathogenesis During Influenza Virus Infection.

Authors: Tan YJ Huber VC Hottz ED

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Nov 09; Vol. 11, pp. 779411. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2021).

Publication Type: Editorial

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE; PubMed not MEDLINE